Chtop is a novel TREX component. The TREX complex couples nuclear pre-mRNA processing with mRNA export and contains multiple protein components
| Institute |
|---|
| Erasmus Medical Center |
| Cat. #: | 156494 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Genetics |
| Application: | IP ; WB |
| Target: | TREX mRNA export complex |
| Host: | Rat |
| Class: | Polyclonal |
| Alternate name: | Chtop; TREX component |
|---|---|
| Product description: | Chtop is a novel TREX component. The TREX complex couples nuclear pre-mRNA processing with mRNA export and contains multiple protein components |
| Conjugation: | Unconjugated |
| Target background: | Chtop is a novel TREX component. The TREX complex couples nuclear pre-mRNA processing with mRNA export and contains multiple protein components |
|---|
| Format: | Liquid |
|---|---|
| Storage buffer: | Serum |
| Shipping conditions: | Dry ice |
| References: |
Chang et al. 2013. EMBO J. 32(3):473-86. PMID: 23299939. van Dijk et al. 2010. Blood. 116(20):4349-52. PMID: 20688955. van Dijk et al. 2010. Mol Cell Biol. 30(1):260-72. PMID: 19858291. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.